{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:49:26Z","timestamp":1723830566258},"reference-count":5,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0378-6323.183628","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T10:45:05Z","timestamp":1465296305000},"page":"577","source":"Crossref","is-referenced-by-count":20,"title":["Bullous pemphigoid successfully treated with omalizumab"],"prefix":"10.25259","volume":"82","author":[{"given":"M\u00fczeyyen","family":"G\u00f6n\u00fcl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HavvaOzge","family":"Keseroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Ergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.183628-1","first-page":"1241","volume-title":"Successful treatment of bullous pemphigoid with omalizumab","author":"London","year":"2012","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183628-2","first-page":"468","volume-title":"Omalizumab therapy for bullous pemphigoid","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183628-3","first-page":"704","volume-title":"Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0378-6323.183628-4","first-page":"523","volume-title":"Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200","author":"Yalcin","year":"2014","journal-title":"Clin Lab"},{"key":"key-10.4103\/0378-6323.183628-5","first-page":"788","volume-title":"Safety and tolerability of omalizumab","author":"Corren","year":"2009","journal-title":"Clin Exp Allergy"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:45:32Z","timestamp":1611917132000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/bullous-pemphigoid-successfully-treated-with-omalizumab\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["183628"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.183628","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}